.svg){kind=small}
Jan-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Experience Premium Cannabis (EPC) has shown notable performance in the Tincture & Sublingual category in Nevada. After not being ranked in the top 30 for October and November 2024, EPC made a significant leap to rank 4th by December 2024, maintaining a strong position with a 5th place ranking in January 2025. This upward trajectory indicates a growing consumer interest and acceptance of their products in this category. The absence of a ranking in the earlier months suggests either a recent entry into this category or an initial struggle to capture market share, making their later success even more impressive.
The sales figures for EPC in Nevada support this narrative, with a noteworthy increase from October to December 2024, followed by a slight decline in January 2025. This pattern of growth and stabilization is crucial for understanding EPC's market dynamics and consumer demand fluctuations. While the detailed sales data is not fully disclosed here, the trends suggest a strategic positioning that has allowed EPC to capitalize on the growing tincture and sublingual market. The initial lack of ranking could be seen as a challenge, yet their ability to break into the top 5 demonstrates resilience and effective market strategies.
Competitive Landscape
In the Nevada Tincture & Sublingual category, Experience Premium Cannabis (EPC) has shown a noteworthy upward trend, breaking into the top 5 by December 2024 and maintaining a solid position at rank 5 in January 2025. This rise is significant, considering the brand was not in the top 20 in the preceding months of October and November 2024. The competitive landscape is dominated by Doctor Solomon's, which consistently holds the top position with sales significantly higher than EPC's, indicating a strong market presence. Meanwhile, Spiked Flamingo maintains a steady second place, with sales figures that are also notably higher than EPC's. Despite these challenges, EPC's entry into the top ranks suggests a positive reception of their products and potential for further growth in this competitive market.
Notable Products
In January 2025, the top-performing product from Experience Premium Cannabis (EPC) was the CBN Good Night Tincture (500mg CBN, 14ml) in the Tincture & Sublingual category, maintaining its number one rank from previous months with sales of 187 units. The CBD/THC 1:1 Golden Mylk Tincture (100mg CBD, 100mg THC) secured the second position, consistently holding this rank since December 2024. The CBD/THC 8:1 Cannabis Tincture (270mg CBD, 30mg THC) improved its standing to third place, up from fourth in December 2024. Notably, the CBD/THC 20:1 Breath Easy Tincture (400mg CBD, 20mg THC, 14ml), which was ranked second in November 2024, did not appear in the January 2025 rankings. Overall, the top products reflect a strong preference for tinctures with balanced CBD/THC ratios among consumers.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
